Enteric-Coated Capsules for Sensitive Active Ingredients
Enteric-coated capsules help protect sensitive active ingredients from stomach acid and release them in the intestinal environment. Studies show gastric pH can range from 1.0 to 3.5, and some acid-sensitive compounds may lose more than 50% activity during exposure without protection. Enteric coating systems using HPMCP, CAP, and methacrylate polymers can maintain capsule integrity for 2–4 hours in acidic conditions and achieve over 85% release under intestinal pH conditions.
Sensitive active ingredients often require special delivery systems because their chemical structure or biological activity can change during digestion. Probiotics, enzymes, peptides, botanical extracts, and some vitamins are among the ingredients most affected by gastric conditions.
For example, probiotic strains such as Lactobacillus and Bifidobacterium may show significant reductions after exposure to simulated stomach fluid. Research published in recent years has reported that unprotected probiotic capsules can lose 1–3 log CFU levels during gastric digestion, while enteric systems can improve survival rates by more than 70% in some formulations.
“The purpose of enteric coating is not only to delay capsule opening but also to control where the active ingredient becomes available.”
This requirement has increased demand for specialized manufacturing services. Many supplement brands work with a capsule contract manufacturer to develop capsules with controlled release properties, stability testing, and production processes suitable for sensitive ingredients.
Enteric-coated capsules use pH-sensitive polymers that remain stable in the stomach but dissolve after reaching the small intestine. The stomach usually maintains a low pH environment, while intestinal pH rises to approximately 5.5–7.5 depending on location and digestive conditions.
The coating material determines the release point. Hydroxypropyl methylcellulose phthalate (HPMCP) may dissolve around pH 5.0–5.5, while methacrylate-based polymers can be adjusted for release closer to pH 6.0–7.0.
Different polymers provide different performance characteristics:
| Coating Material | Typical Release pH | Common Use |
|---|---|---|
| Cellulose acetate phthalate (CAP) | About 6.0–7.0 | Pharmaceutical delayed release |
| HPMCP | About 5.0–5.5 | Early intestinal delivery |
| Methacrylate copolymers | About 5.5–7.0 | Controlled intestinal release |
| Shellac | Around 6.5–7.0 | Nutraceutical products |
The selection of coating materials must consider ingredient stability, storage conditions, and release requirements. A formulation designed for probiotics may require different coating properties compared with one designed for enzymes or plant extracts.
Manufacturing accuracy directly affects enteric capsule performance. During production, coating thickness, polymer concentration, spray rate, and drying temperature must be carefully controlled.
A coating layer that is too thin may allow acid penetration before intestinal arrival. A coating layer that is too thick may delay release beyond the intended location. In industrial production, coating weight gain is often controlled within specific ranges, and even a 1–2% variation in coating amount may influence dissolution behavior.
Fluid-bed coating systems are commonly used because they provide more uniform polymer distribution compared with manual coating methods. Temperature control is also important because excessive heat can affect both the coating layer and sensitive active ingredients.
“A stable enteric capsule depends on both the polymer system and the manufacturing process used to apply it.”
Quality testing usually includes several stages before commercial release. Manufacturers evaluate acid resistance, intestinal dissolution, moisture stability, capsule strength, and active ingredient retention.
Common evaluation methods include:
-
Acid stage testing for 1–2 hours under simulated gastric conditions
-
Buffer stage testing under intestinal pH conditions
-
Active ingredient analysis before and after storage
-
Moisture exposure studies at controlled humidity levels
Storage conditions influence long-term capsule performance. Research has shown that high humidity environments above 60% relative humidity may affect capsule shell properties and coating stability over extended periods.
Packaging selection is therefore important for enteric products. Aluminum blister packs, high-barrier bottles, and desiccant systems are commonly used to reduce moisture exposure.
Sensitive ingredients have different protection requirements depending on their chemical properties. Probiotics require protection mainly from acid and moisture, while omega-3 oils require protection from oxidation.
A comparison of common applications:
| Active Ingredient | Main Concern | Enteric Capsule Benefit |
|---|---|---|
| Probiotics | Low survival in stomach acid | Higher intestinal delivery |
| Digestive enzymes | Protein structure changes | Better enzyme activity preservation |
| Fish oil | Oxidation and taste issues | Reduced upper GI release |
| Peptides | Acid degradation | Improved stability |
| Botanical extracts | pH sensitivity | More controlled release |
The growing use of functional ingredients has increased interest in delayed-release capsule technology. The global dietary supplement industry has expanded significantly since 2015, with probiotics, digestive health products, and plant-based supplements representing major application areas.
Enteric capsules are also used for ingredients that may irritate the stomach. Some compounds can cause discomfort when released in the upper gastrointestinal tract, so delayed release helps move delivery toward the small intestine.
“The release location can influence ingredient performance, absorption conditions, and user experience.”
Product development requires cooperation between ingredient suppliers, formulation specialists, and capsule manufacturers. Parameters such as capsule size, fill weight, active ingredient concentration, and coating compatibility must be evaluated together.
For example, a high-dose botanical extract may require a larger capsule size or multiple capsules per serving, while a concentrated probiotic product may focus more on moisture protection and bacterial survival.
Modern enteric capsule development also uses advanced testing tools. Dissolution analyzers, chromatography methods, and stability studies help manufacturers measure ingredient retention over time.
In a typical stability program, products may be tested at conditions such as 25°C/60% RH or accelerated conditions of 40°C/75% RH. Testing periods of 6 months or 12 months are commonly used to evaluate product quality before market release.
Future enteric capsule systems are moving toward more customized delivery approaches. Researchers are exploring biodegradable polymers, natural coating materials, and formulations designed for specific intestinal regions.
As more supplement products include probiotics, peptides, and plant-derived compounds, enteric-coated capsules will continue to be used for improving ingredient protection and delivery accuracy. The combination of suitable polymers, controlled manufacturing, and reliable testing allows sensitive active ingredients to maintain better stability from production to consumption.